Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Johnson & Johnson subsidiary DePuy Synthes today touted 4-year data from a large registry study showing that its Attune knee implant had a lower revision rate than the overall rate for total knee replacement.
The study examined data from 10,605 Attune implantations in Britain’s National Joint Registry for England, Wales, Northern Ireland & the Isle of Man, finding that the revision rate for Attune was 1.3% at 4 years, compared with the registry’s 1.9% average. Just 46 of the Attune knee procedures required revision, DePuy Synthes said. Read more
Medtronic said today that it’s starting a large study on the effect of pulse oximetry and capnography in opioid-induced respiratory depression, using its Capnostream device.
The 1,650-patient Prodigy study aims to create a tool to score the risk of OIRD in patients being treated with opioids for pain, using Capnostream’s continuous pulse oximetry and capnography monitoring over 48 hours. The study is slated for a final data collection for the primary outcome in February 2018 and an estimated completion date a month later, according to ClinicalTrials.gov. Read more
Researchers from the security research firm WhiteScope identified cyber vulnerabilities in file system encryption and in the storage of unencrypted patient data across major vendors of implantable cardiac devices, according to the team’s report.
“The findings reveal consistency across all vendors, highlighting the inherent weaknesses in the ecosystem architecture,” the firm wrote. Read more
AngioDynamics said it leveled an anti-trust lawsuit against C.R. Bard, alleging that the larger company illegally ties the sales of its peripherally inserted central catheters to its tip location devices.
The lawsuit, filed today in the U.S. District Court for Northern New York, accuses Bard of maintaining its dominant position in the tip location market by only selling its proprietary offering with its own catheters. Read more
Intuitive Surgical said today it won FDA 510(k) clearance for its new da Vinci X robotic surgical system, with a planned release of the platform later this year.
The newly cleared da Vinci X system offers access to multiple robotic-assisted surgical technologies at a lower price than previous models, the Sunnyvale, Calif.-based company said. The system operates on the same vision cart and surgeon consoles used by the company’s flagship da Vinci Xi system. Read more